149 related articles for article (PubMed ID: 16845408)
21. B-RAF and melanocytic neoplasia.
Gill M; Celebi JT
J Am Acad Dermatol; 2005 Jul; 53(1):108-14. PubMed ID: 15965430
[TBL] [Abstract][Full Text] [Related]
22. Molecular epidemiology of skin cancers: DNA repair and non-melanocytic skin cancer.
Hall J; Artuso M; English DR
Ann Ist Super Sanita; 1996; 32(1):43-51. PubMed ID: 8967724
[TBL] [Abstract][Full Text] [Related]
23. Sensitive allele-specific real-time PCR test for mutations in BRAF codon V600 in skin melanoma.
Pisareva E; Gutkina N; Kovalenko S; Kuehnapfel S; Hartmann A; Heinzerling L; Schneider-Stock R; Lyubchenko L; Shamanin VA
Melanoma Res; 2014 Aug; 24(4):322-31. PubMed ID: 24922189
[TBL] [Abstract][Full Text] [Related]
24. UV wavelength-dependent DNA damage and human non-melanoma and melanoma skin cancer.
Pfeifer GP; Besaratinia A
Photochem Photobiol Sci; 2012 Jan; 11(1):90-7. PubMed ID: 21804977
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of BRAF(V⁶⁰⁰) mutations in melanoma patients after resection of metastatic lymph nodes.
Moreau S; Saiag P; Aegerter P; Bosset D; Longvert C; Hélias-Rodzewicz Z; Marin C; Peschaud F; Chagnon S; Zimmermann U; Clerici T; Emile JF
Ann Surg Oncol; 2012 Dec; 19(13):4314-21. PubMed ID: 22772867
[TBL] [Abstract][Full Text] [Related]
26. High BRAF mutation frequency does not characterize all melanocytic tumor types.
Saldanha G; Purnell D; Fletcher A; Potter L; Gillies A; Pringle JH
Int J Cancer; 2004 Sep; 111(5):705-10. PubMed ID: 15252839
[TBL] [Abstract][Full Text] [Related]
27. BRAF/NRAS wild-type melanomas have a high mutation load correlating with histologic and molecular signatures of UV damage.
Mar VJ; Wong SQ; Li J; Scolyer RA; McLean C; Papenfuss AT; Tothill RW; Kakavand H; Mann GJ; Thompson JF; Behren A; Cebon JS; Wolfe R; Kelly JW; Dobrovic A; McArthur GA
Clin Cancer Res; 2013 Sep; 19(17):4589-98. PubMed ID: 23833303
[TBL] [Abstract][Full Text] [Related]
28. Recent progress in understanding the pathology of malignant melanoma.
Kuphal S; Bosserhoff A
J Pathol; 2009 Dec; 219(4):400-9. PubMed ID: 19771562
[TBL] [Abstract][Full Text] [Related]
29. Method of mutation analysis may contribute to discrepancies in reports of (V599E)BRAF mutation frequencies in melanocytic neoplasms.
Miller CJ; Cheung M; Sharma A; Clarke L; Helm K; Mauger D; Robertson GP
J Invest Dermatol; 2004 Nov; 123(5):990-2. PubMed ID: 15482489
[No Abstract] [Full Text] [Related]
30. Chromosomal translocations as a mechanism of BRAF activation in two cases of large congenital melanocytic nevi.
Dessars B; De Raeve LE; El Housni H; Debouck CJ; Sidon PJ; Morandini R; Roseeuw D; Ghanem GE; Vassart G; Heimann P
J Invest Dermatol; 2007 Jun; 127(6):1468-70. PubMed ID: 17301836
[TBL] [Abstract][Full Text] [Related]
31. NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing.
Edlundh-Rose E; Egyházi S; Omholt K; Månsson-Brahme E; Platz A; Hansson J; Lundeberg J
Melanoma Res; 2006 Dec; 16(6):471-8. PubMed ID: 17119447
[TBL] [Abstract][Full Text] [Related]
32. Detection of BRAF V600 mutations in metastatic melanoma: comparison of the Cobas 4800 and Sanger sequencing assays.
Qu K; Pan Q; Zhang X; Rodriguez L; Zhang K; Li H; Ho A; Sanders H; Sferruzza A; Cheng SM; Nguyen D; Jones D; Waldman F
J Mol Diagn; 2013 Nov; 15(6):790-5. PubMed ID: 23994118
[TBL] [Abstract][Full Text] [Related]
33. Molecular pathogenesis of malignant melanoma: a different perspective from the studies of melanocytic nevus and acral melanoma.
Takata M; Murata H; Saida T
Pigment Cell Melanoma Res; 2010 Feb; 23(1):64-71. PubMed ID: 19788535
[TBL] [Abstract][Full Text] [Related]
34. Elevated pyrimidine dimer formation at distinct genomic bases underlies promoter mutation hotspots in UV-exposed cancers.
Elliott K; Boström M; Filges S; Lindberg M; Van den Eynden J; Ståhlberg A; Clausen AR; Larsson E
PLoS Genet; 2018 Dec; 14(12):e1007849. PubMed ID: 30586386
[TBL] [Abstract][Full Text] [Related]
35. BRAF mutations are common somatic events in melanocytic nevi.
Kumar R; Angelini S; Snellman E; Hemminki K
J Invest Dermatol; 2004 Feb; 122(2):342-8. PubMed ID: 15009715
[TBL] [Abstract][Full Text] [Related]
36. TP63 mutations are frequent in cutaneous melanoma, support UV etiology, but their role in melanomagenesis is unclear.
Monti P; Ghiorzo P; Menichini P; Foggetti G; Queirolo P; Izzotti A; Fronza G
Oncol Rep; 2017 Oct; 38(4):1985-1994. PubMed ID: 28849221
[TBL] [Abstract][Full Text] [Related]
37. Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis.
Lee JH; Choi JW; Kim YS
Br J Dermatol; 2011 Apr; 164(4):776-84. PubMed ID: 21166657
[TBL] [Abstract][Full Text] [Related]
38. SnapshotDx Quiz: March 2018.
Gaddis K; Chu EY
J Invest Dermatol; 2018 Mar; 138(3):e31. PubMed ID: 29477193
[No Abstract] [Full Text] [Related]
39. BRAF wild-type melanoma in situ arising in a BRAF V600E mutant dysplastic nevus.
Tan JM; Lin LL; Lambie D; Flewell-Smith R; Jagirdar K; Schaider H; Sturm RA; Prow TW; Soyer HP
JAMA Dermatol; 2015 Apr; 151(4):417-21. PubMed ID: 25607474
[TBL] [Abstract][Full Text] [Related]
40. Detection of the BRAF V600E mutation in melanocytic lesions using the ligase detection reaction.
Turner DJ; Zirvi MA; Barany F; Elenitsas R; Seykora J
J Cutan Pathol; 2005 May; 32(5):334-9. PubMed ID: 15811117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
